An ultrastructural analysis of platelets, erythrocytes, white blood cells, and fibrin network in systemic lupus erythematosus

Rheumatology International

Volumn 34, Issue 7, 2014, Pages 1005-1009

  Pretorius, Etheresia ^a   Du Plooy, Jenny ^a   Soma, Prashilla ^a   Gasparyan, Armen Yuri ^b  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b RUSSELLS HALL HOSPITAL   (United Kingdom)

Author keywords

Electron microscopy; Erythrocytes; Fibrin; Platelet function; Systemic lupus erythematosus; White blood cells

Indexed keywords

FIBRIN;

ADULT; ARTICLE; BLOOD SAMPLING; CELL INTERACTION; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROCYTE STRUCTURE; FEMALE; HUMAN; HUMAN CELL; INFLAMMATORY CELL; LEUKOCYTE; LEUKOCYTE STRUCTURE; MALE; PLATELET MICROPARTICLE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE; THROMBOCYTE STRUCTURE; BLOOD; BLOOD BUFFY COAT; CELL COMMUNICATION; CYTOLOGY; IMMUNOLOGY; MEMBRANE MICROPARTICLE; METABOLISM; PATHOLOGY; SCANNING ELECTRON MICROSCOPY; THROMBOCYTE ACTIVATION; THROMBOCYTE RICH PLASMA; THROMBOSIS; ULTRASTRUCTURE; YOUNG ADULT;

ADULT; BLOOD BUFFY COAT; BLOOD PLATELETS; CELL COMMUNICATION; CELL-DERIVED MICROPARTICLES; ERYTHROCYTES; FEMALE; FIBRIN; HUMANS; LEUKOCYTES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICROSCOPY, ELECTRON, SCANNING; PLATELET ACTIVATION; PLATELET-RICH PLASMA; THROMBOSIS; YOUNG ADULT;

EID: 84903301627     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-013-2817-x     Document Type: Article

References (21)

1. Tsokos GC (2011) Systemic lupus erythematosus. N Engl J Med 365(22):2110-2121. doi:10.1056/NEJMra1100359
2. Swadzba J, Iwaniec T, Musial J (2011) Increased level of tumor necrosis factor-α in patients with antiphospholipid syndrome: marker not only of inflammation but also of the prothrombotic state. Rheumatol Int 31(3):307-313. doi:10.1007/s00296-009-1314-8
3. Bertsias GK, Salmon JE, Boumpas DT (2010) Therapeutic opportunities in systemic lupus erythematosus: state of the art and prospects for the new decade. Ann Rheum Dis 69(9):1603-1611. doi:10.1136/ard.2010.135186
4. Gasparyan AY, Stavropoulos-Kalinoglou A, Mikhailidis DP, Toms TE, Douglas KM, Kitas GD (2010) The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases. Curr Vasc Pharmacol 8(4):437-449. doi:10.2174/157016110791330852
5. Mashhadi MA, Bari Z (2011) Thrombotic thrombocytopenic purpura and deep vein thrombosis as the presenting manifestations of systemic lupus erythematosus: a case report and review of literature. J Res Med Sci 16(8):1082-1088
6. Boilard E, Blanco P, Nigrovic PA (2012) Platelets: active players in the pathogenesis of arthritis and SLE. Nat Rev Rheumatol 8(9):534-542. doi:10.1038/nrrheum.2012.118
7. Satoh T, Tanaka Y, Okazaki Y, Kaburaki J, Ikeda Y, Kuwana M (2012) Heparin-dependent and -independent anti-platelet factor 4 autoantibodies in patients with systemic lupus erythematosus. Rheumatology (Oxford) 51(9):1721-1728. doi:10.1093/rheumatology/kes145
8. Hrycek A, Cieślik P (2012) Annexin A5 and anti-annexin antibodies in patients with systemic lupus erythematosus. Rheumatol Int 32(5):1335-1342. doi:10.1007/s00296-011-1793-2
9. Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD (2011) Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des 17(1):47-58. doi:10.2174/138161211795049804
10. Spengler MI, Svetaz MJ, Leroux MB, Bertoluzzo SM, Carrara P, Van Isseldyk F, Petrelli D, Parente FM, Bosch P (2011) Erythrocyte aggregation in patients with systemic lupus erythematosus. Clin Hemorheol Microcirc 47(4):279-285. doi:10.3233/CH-2011-1409
11. Ghiran IC, Zeidel ML, Shevkoplyas SS, Burns JM, Tsokos GC, Kyttaris VC (2011) Systemic lupus erythematosus serum deposits C4d on red blood cells, decreases red blood cell membrane deformability, and promotes nitric oxide production. Arthritis Rheum 63(2):503-512. doi:10.1002/art.30143
12. Midgley A, McLaren Z, Moots RJ, Edwards SW, Beresford MW (2009) The role of neutrophil apoptosis in juvenile-onset systemic lupus erythematosus. Arthritis Rheum 60(8):2390-2401. doi:10.1002/art.24634
13. Gladigau G, Haselmayer P, Scharrer I, Munder M, Prinz N, Lackner K, Schild H, Stein P, Radsak MP (2012) A role for toll-like receptor mediated signals in neutrophils in the pathogenesis of the anti-phospholipid syndrome. PLoS One 7(7):e42176. doi:10.1371/journal.pone.0042176
14. Aksu K, Donmez A, Keser G (2012) Inflammation-induced thrombosis: mechanisms, disease associations and management. Curr Pharm Des 18(11):1478-1493. doi:10.2174/138161212799504731
15. Gasparyan AY, Stavropoulos-Kalinoglou A, Mikhailidis DP, Douglas KM, Kitas GD (2011) Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications. Rheumatol Int 31(2):153-164. doi:10.1007/s00296- 010-1446-x
16. La Regina M, Gasparyan AY, Orlandini F, Prisco D (2010) Behçet's disease as a model of venous thrombosis. Open Cardiovasc Med J 4:71-77. doi:10.2174/1874192401004020071
17. Pretorius E, Oberholzer HM, van der Spuy WJ, Swanepoel AC, Soma P (2012) Scanning electron microscopy of fibrin networks in rheumatoid arthritis: a qualitative analysis. Rheumatol Int 32(6):1611-1615. doi:10.1007/s00296-011- 1805-2
18. Porto I, De Maria GL, Di Vito L, Camaioni C, Gustapane M, Biasucci LM (2011) Microparticles in health and disease: small mediators, large role? Curr Vasc Pharmacol 9(4):490-500. doi:10.2174/157016111796197206
19. Nielsen CT, Østergaard O, Johnsen C, Jacobsen S, Heegaard NH (2011) Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus. Arthritis Rheum 63(10):3067-3077. doi:10.1002/art.30499
20. Piccin A, Murphy WG, Smith OP (2007) Circulating microparticles: pathophysiology and clinical implications. Blood Rev 21(3):157-171. doi:10.1016/j.blre.2006.09.001 (Pubitemid 46529055)
21. Lipinski B, Pretorius E, Oberholzer HM, van der Spuy WJ (2012) Interaction of fibrin with red blood cells: the role of iron. Ultrastruct Pathol 36(2):79-84. doi:10.3109/01913123.2011.627491